FDA Sued Over Genetically-engineered Salmon 

Naturopathic News

According to an article published online by EcoWatch, the Center for Food Safety and other organizations are suing the FDA over their recent approval of the first-ever genetically (GE) food animal, an Atlantic salmon that is engineered to grow quickly, created by AquaBounty Technologies Inc. the engineered fish is made from DNA from three fish: Atlantic salmon, Pacific king salmon and Arctic ocean eelpout.

Opponents of the FDA’s approval note that this means there is no requirement to label the GE fish. Also, the FDA disregarded comments from nearly two million people who opposed the decision because of the lack of environmental analysis. One danger is that the GE salmon could escape and threaten endangered wild salmon stocks.

One lobbyist for Friends of the Earth noted, “It’s clear that the market has rejected GE salmon despite FDA’s reckless approval,” she said. “Major retailers including Costco, Safeway and Kroger won’t sell it and polls show the vast majority of people don’t want to eat it. Yet under this approval it won’t be labeled, violating our fundamental right to know what we are feeding our families.”

Learn more about GMOs and their role in disease at the Natural Cancer Prevention Summit


raziRazi Berry, Founder and Publisher of Naturopathic Doctor News & Review (ndnr.com) and NaturalPath (thenatpath.com), has spent the last decade as a natural medicine advocate and marketing whiz. She has galvanized and supported the naturopathic community, bringing a higher quality of healthcare to millions of North Americans through her publications. A self-proclaimed health-food junkie and mother of two; she loves all things nature, is obsessed with organic gardening, growing fruit trees (not easy in Phoenix), laughing until she snorts, and homeschooling. She is a little bit crunchy and yes, that is her real name.

Advertisement

Current Issue

Table of Contents

Advertisement

Trending Articles

Restorative Formulations Launches the NeuroSynergy Clinical Series

Restorative Formulations Launches the NeuroSynergy Clinical Series

Four professional-grade formulas targeting distinct neurochemical pathways to support  mood, stress resilience, and cognitive function are now available exclusively to licensed  practitioners.  Montpelier, VT, March 27, 2026 — Restorative Formulations has released the...

Allergy Research News Release

Allergy Research News Release

RAZI BERRY Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science Collaborative research led by ARG’s Medical Affairs and Scientific Advisory Board reinforces the company’s commitment to thyroid category...

Three Endocrine Axes Share One Energy Budget for Stress Resilience

Three Endocrine Axes Share One Energy Budget for Stress Resilience

Three Endocrine Axes Share One Energy Budget for Stress Resilience Mitochondrial reserve capacity constrains the HPA, thyroid, and gonadal systems simultaneously, determining whether stress responses stay adaptive or consolidate into chronic dysfunction. When a...

Custom Publishing

Quantum Energy Effects on Cell Recovery Rates

Quantum Energy Effects on Cell Recovery Rates

Author: Robert Sheaff, PhD, and Ian Mitchell Abstract This study investigated whether quantum field exposure generated by Leela Quantum Bloc Technology influences cell recovery rates in human cell lines. A series of double-blind experiments were conducted using Human...

Quantum Fields and Frequency Medicine

RAZI BERRY Quantum Fields and Frequency Medicine A Conversation with Philipp Samor von Holtzendorff Fehling on Remote Quantum Technology and Human Performance Interest in frequency medicine and subtle energy technologies continues to grow...

Featured News